IRIS
BREMBILLA, GIORGIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 195
EU - Europa 174
AS - Asia 44
OC - Oceania 3
SA - Sud America 1
Totale 417
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 195
IT - Italia 85
SE - Svezia 63
CN - Cina 31
DE - Germania 6
FI - Finlandia 6
IE - Irlanda 6
IN - India 4
AU - Australia 3
GB - Regno Unito 3
HK - Hong Kong 3
BG - Bulgaria 2
FR - Francia 2
JP - Giappone 2
MY - Malesia 2
TW - Taiwan 2
NL - Olanda 1
PY - Paraguay 1
Totale 417
Salva come PNG Salva come JPEG
Città #
Milan 40
New York 38
Ashburn 28
Shanghai 20
Lawrence 16
Princeton 16
Los Angeles 10
Suzhou 10
Rome 9
Washington 8
Dublin 6
Helsinki 6
Council Bluffs 4
Naples 3
Paderborn 3
Bergamo 2
Bethesda 2
Bolzano 2
Canberra 2
Caponago 2
Falconara Marittima 2
Guwahati 2
Hong Kong 2
Kuala Lumpur 2
Palermo 2
Pune 2
Razgrad 2
Rochester 2
Seattle 2
Taipei 2
Vigonza 2
Aix-en-Provence 1
Asunción 1
Bari 1
Chicago 1
Freiburg im Breisgau 1
Giussano 1
Kunming 1
London 1
Lucca 1
Neyagawa 1
Romford 1
Segrate 1
Springfield 1
Stanghella 1
Sydney 1
Torrile 1
Treviso 1
Tuscania 1
Totale 267
Salva come PNG Salva come JPEG
Nome #
Simplification of prostate MRI protocol and development of a novel MRI technique for prostate cancer detection and characterization 46
How to optimize follow-up in patients with a suspicious multiparametric MRI and a subsequent negative targeted prostate biopsy. Results from a large, single-institution series 31
MRI-Targeted or Standard Biopsy for Prostate-Cancer Diagnosis 24
Impact of prostate imaging quality (PI-QUAL) score on the detection of clinically significant prostate cancer at biopsy 23
Can DCE-MRI reduce the number of PI-RADS v.2 false positive findings? Role of quantitative pharmacokinetic parameters in prostate lesions characterization 21
External validation of a convolutional neural network for the automatic segmentation of intraprostatic tumor lesions on 68Ga-PSMA PET images 20
Age and gleason score upgrading between prostate biopsy and radical prostatectomy: Is this still true in the multiparametric resonance imaging era? 20
68Ga-PSMA and 68Ga-DOTA-RM2 PET/MRI in Recurrent Prostate Cancer: Diagnostic Performance and Association with Clinical and Histopathological Data 20
Role of [68Ga]Ga-PSMA-11 PET radiomics to predict post-surgical ISUP grade in primary prostate cancer 19
Preliminary results of an ongoing prospective clinical trial on the use of68ga-psma and68ga-dota-rm2 pet/mri in staging of high-risk prostate cancer patients 18
Embolization of superior rectal arteries for transfusion dependent haemorrhoidal bleeding in severely cardiopathic patients: a new field of application of the “emborrhoid” technique 17
[68Ga]Ga-PSMA and [68Ga]Ga-RM2 PET/MRI vs. Histopathological Images in Prostate Cancer: A New Workflow for Spatial Co-Registration 15
Impact of prostate MRI central review over the diagnostic performance of MRI-targeted biopsy: should we routinely ask for an expert second opinion? 15
Prostate-specific membrane antigen Radioguided Surgery to Detect Nodal Metastases in Primary Prostate Cancer Patients Undergoing Robot-assisted Radical Prostatectomy and Extended Pelvic Lymph Node Dissection: Results of a Planned Interim Analysis of a Prospective Phase 2 Study 15
Assessing the Clinical Value of Positive Multiparametric Magnetic Resonance Imaging in Young Men with a Suspicion of Prostate Cancer 15
Interreader variability in prostate MRI reporting using Prostate Imaging Reporting and Data System version 2.1 14
Advanced Imaging Analysis in Prostate MRI: Building a Radiomic Signature to Predict Tumor Aggressiveness 13
Beyond diagnosis: is there a role for radiomics in prostate cancer management? 12
Pancreatic metastases after surgery for renal cell carcinoma: survival and pathways of progression 12
MpMRI of the prostate: is there a role for semi-quantitative analysis of DCE-MRI and late gadolinium enhancement in the characterisation of prostate cancer? 11
Preoperative multiparametric MRI of the prostate for the prediction of lymph node metastases in prostate cancer patients treated with extended pelvic lymph node dissection 11
Assessing the need for systematic biopsies in addition to targeted biopsies according to the characteristics of the index lesion at mpMRI. Results from a large, multi-institutional database 10
Does previous prostate surgery affect multiparametric magnetic resonance imaging accuracy in detecting clinically significant prostate cancer? Results from a single institution series 10
US/TOF-PET endorectal probe compatible with MR, for diagnosis and staging of the prostate cancer 10
Diagnostic Accuracy of Abbreviated Bi-Parametric MRI (a-bpMRI) for Prostate Cancer Detection and Screening: A Multi-Reader Study 10
ReIMAGINE Prostate Cancer Screening Study: protocol for a single-centre feasibility study inviting men for prostate cancer screening using MRI 9
Not All Multiparametric Magnetic Resonance Imaging–targeted Biopsies Are Equal: The Impact of the Type of Approach and Operator Expertise on the Detection of Clinically Significant Prostate Cancer 9
Diagnostic accuracy of fully hybrid [68Ga]Ga-PSMA-11 PET/MRI and [68Ga]Ga-RM2 PET/MRI in patients with biochemically recurrent prostate cancer: a prospective single-center phase II clinical trial 8
Tackling Interobserver Variability in Multiparametric Magnetic Resonance Imaging (MRI): Is MRI Even Better than We Think for Prostate Cancer Diagnosis? 8
Update from the ReIMAGINE Prostate Cancer Screening Study NCT04063566: Inviting Men for Prostate Cancer Screening Using Magnetic Resonance Imaging 7
Quantification of Prostate Cancer Metabolism Using 3D Multiecho bSSFP and Hyperpolarized [1-13 C] Pyruvate: Metabolism Differs Between Tumors of the Same Gleason Grade 7
Association Between Prostate Imaging Reporting and Data System (PI-RADS) Score for the Index Lesion and Multifocal, Clinically Significant Prostate Cancer 7
There Is No Way to Avoid Systematic Prostate Biopsies in Addition to Multiparametric Magnetic Resonance Imaging Targeted Biopsies 7
Therapeutic EUS: Biliary drainage - The interventional radiologist's perspective 5
Variability of mpMRI diagnostic performance according to the upfront individual patient risk of having clinically significant prostate cancer 4
Preoperative risk calculator for the probability of completing nephron sparing for kidney cancer 1
Totale 504
Salva come PNG Salva come JPEG
Categoria #
all - tutte 5.155
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.155
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20209 4 3 0 0 1 0 0 0 1 0 0 0
2020/20214 0 0 0 0 1 2 0 0 0 0 1 0
2021/202212 0 4 1 2 0 1 3 1 0 0 0 0
2022/2023183 40 22 13 10 3 13 10 13 4 5 32 18
2023/2024288 6 22 36 33 28 76 10 30 5 40 2 0
Totale 504